We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
-9.53%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$108M
AUM Growth
-$23.8M
Cap. Flow
-$9.19M
Cap. Flow %
-8.52%
Top 10 Hldgs %
78.01%
Holding
130
New
11
Increased
10
Reduced
18
Closed
65

Sector Composition

Rank Sector Weight
1 Technology 40.34%
2 Healthcare 22.33%
3 Financials 11.89%
4 Consumer Discretionary 9.06%
5 Communication Services 2.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIMB icon
26
TIM SA
TIMB
$8.62B
$148K 0.14%
+12,200
New +$217K
AKBA icon
27
Akebia Therapeutics
AKBA
$240M
$89K 0.08%
11,800
-1,900
-14% -$14.8K
OSG
28
DELISTED
Overseas Shipholding Group Inc.
OSG
$79K 0.07%
35,000
MEET
29
DELISTED
The Meet Group, Inc. Common Stock
MEET
$79K 0.07%
13,400
-3,900
-23% -$22.2K
RBBN icon
30
Ribbon Communications
RBBN
$356M
$78K 0.07%
25,600
ATEN icon
31
A10 Networks
ATEN
$1.97B
$66K 0.06%
10,700
IDT icon
32
IDT Corp
IDT
$1.63B
$66K 0.06%
12,100
-5,500
-31% -$39.3K
SPWH icon
33
Sportsman's Warehouse
SPWH
$46.8M
$66K 0.06%
10,700
-2,500
-19% -$15.6K
PDLI
34
DELISTED
PDL BioPharma, Inc.
PDLI
$65K 0.06%
22,900
-1,000
-4% -$3.22K
CRBP icon
35
Corbus Pharmaceuticals
CRBP
$184M
$64K 0.06%
407
DAKT icon
36
Daktronics
DAKT
$1.02B
$64K 0.06%
12,900
CPRX
37
DELISTED
Catalyst Pharmaceutical
CPRX
$61K 0.06%
15,800
LAB icon
38
Standard BioTools
LAB
$309M
$60K 0.06%
23,800
SIGA icon
39
SIGA Technologies
SIGA
$207M
$60K 0.06%
+12,600
New +$61.4K
PXLW icon
40
Pixelworks
PXLW
$38.3M
$57K 0.05%
1,667
-983
-37% -$45.8K
AFMD
41
DELISTED
Affimed
AFMD
$53K 0.05%
3,370
CDMO
42
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$53K 0.05%
10,300
JNCE
43
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$51K 0.05%
10,700
GALT icon
44
Galectin Therapeutics
GALT
$316M
$50K 0.05%
25,300
-4,900
-16% -$11.9K
MNKD icon
45
MannKind Corp
MNKD
$1.23B
$50K 0.05%
48,600
RLGT icon
46
Radiant Logistics
RLGT
$391M
$50K 0.05%
12,900
-4,700
-27% -$21.7K
DHX icon
47
DHI Group
DHX
$166M
$47K 0.04%
21,700
-7,500
-26% -$20.1K
VKTX icon
48
Viking Therapeutics
VKTX
$3.94B
$47K 0.04%
10,100
TCRT icon
49
Alaunos Therapeutics
TCRT
$4.81M
$46K 0.04%
126
+35
+38% +$18.1K
MNOV icon
50
MediciNova
MNOV
$65M
$44K 0.04%
11,700

Similar funds

HighVista Strategies's Q1 2020 Portfolio in Review

As of Q1 2020, HighVista Strategies held 130 positions worth $108M, down 18% from $132M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

HighVista Strategies withdrew a net $9.19M in Q1 2020, closing 65 positions and reducing 18 holdings. Its most notable exit was Booking.com, an estimated $4.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 40% a quarter earlier, followed by Healthcare and Financials.

Against the trend, HighVista Strategies opened a new position in TD Ameritrade Holding Corp worth $5.53M.

  • HighVista Strategies's largest Q1 2020 buy was TD Ameritrade Holding Corp: 159,630 shares worth $5.53M.
  • HighVista Strategies added most to Allergan plc in Q1 2020, an estimated $17.2M increase.
  • HighVista Strategies's biggest Q1 2020 reduction was Novo Nordisk, cutting an estimated $1.05M.
  • HighVista Strategies fully exited Booking.com in Q1 2020, selling an estimated $4.11M.
  • HighVista Strategies's ten largest holdings make up 78% of its $108M portfolio in Q1 2020.
  • HighVista Strategies opened 11 new positions and closed 65 in Q1 2020.
  • HighVista Strategies's portfolio value fell 18% quarter-over-quarter to $108M.

Based on HighVista Strategies's 13F filing for Q1 2020, filed 15 May 2020.